Mayo Clinic Metabolomics Resource Core
梅奥诊所代谢组学资源核心
基本信息
- 批准号:8619816
- 负责人:
- 金额:$ 191.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-10 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgingAlzheimer&aposs DiseaseAmericanAmino AcidsAppearanceArizonaBasic ScienceBicarbonatesBiochemical PathwayBioinformaticsBiological MarkersBiostatistics CoreCarbohydratesCardiovascular systemCellsCerebrospinal FluidCitric AcidClinicClinicalClinical InvestigatorClinical ResearchCollaborationsComprehensive Cancer CenterDataData AnalysesDiabetes MellitusDiseaseEducationEducation and OutreachEducational CurriculumEducational workshopFatty AcidsFeasibility StudiesFloridaFundingGenomicsGlucoseGlycerolGoalsHealthHealthcareHumanIn VitroInformation TechnologyInstitutionJointsKeto AcidsKineticsLabelLipidsLiquid substanceMagnetic Resonance ImagingMalignant NeoplasmsMapsMass Spectrum AnalysisMeasurementMeasuresMedicineMetabolicMetabolic PathwayMetabolismMethodologyMethodsMinnesotaNMR SpectroscopyObesityOklahomaPathway interactionsPatient CarePharmacogenomicsPhysiologyPilot ProjectsPlasmaProductionProteinsProteomicsProtocols documentationRecording of previous eventsRecoveryRegenerative MedicineRelative (related person)Request for ApplicationsResearchResearch DesignResearch InfrastructureResearch PersonnelResourcesScientistServicesSphingolipidsStable Isotope LabelingStimulusStructureTechniquesTechnologyTissuesTrainingTraining ProgramsTraining and EducationTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesVisitWorkbasecareer developmentclinical applicationclinical practiceimprovedin vivoinnovationinstrumentationmathematical modelmetabolomicsmicrobiomenovelnutritionpostdoctoral investigatorpre-doctoralpreventprogramsresponsesample collectionstable isotopetooltranslational approach
项目摘要
DESCRIPTION: The Mayo Clinic Comprehensive Metabolomics Research Core (MCCMRC) integrates mass spectrometry and NMR Spectroscopy to measure metabolite concentrations and their in vivo dynamics using state of the art Stable isotope techniques. In addition, we propose an outreach and education program which will support feasibility studies and provide education and training opportunities to investigators wishing to utilize these techniques. The MCCMRC will expand services over those currently provided to cater the increasing needs of investigators at a regional and national level. Our services include large scale and targeted metabolomic profiling and measurement of stable isotopes in multiple metabolites, in an integrated fashion that allows us to track changes in metabolite concentration and the underlying rates of appearance and disappearance. This will enable mapping of alterations in dynamic metabolic networking in physiology as well as in pathological states. Clinique features of our program include the use of stable isotopes in diabetes, aging, cardiovascular and lipid research as well as phospometabolomic and pharmacometabolomic approaches. The program is integrated with the Proteomic, Genomic and Pharmacogenomic centers and is supported by a common Bioinformatics/biostatistics core. In addition, we are integrated closely to the major translational research programs in Mayo Clinic including the Centers of Individualized Medicine, Regenerative Medicine, Cancer, Alzheimer, Microbiome and Aging as well as the CTSA. This allows rapid translation of the findings to clinical practice thereby improving human health and patient care. The application offers an opportunity to develop networks with other national centers offering translational approaches to metabolomic technology. We will offer analytical services as well as expertise on study design, mathematical modeling, sample collection and data analysis to institutional, regional and national investigators. MCCMRC will expand our ability to offer a visiting scientists program of workshops, short-term training and didactic courses in order to educate them on the potential of metabolomics tools for research but also on the application of these techniques to their research protocols. In addition, we will leverage institutional training and career development and develop a curriculum and hands-on training program centered on metabolic training in the participating institutions. We will also offer pilot and feasibility funds to pursue innovative approaches to research based on metabolomics. The MCCMRC has an administrative core that will coordinate and integrate all activities of the education, training and feasibility program as well as the technology cores.
描述:梅奥诊所综合代谢组学研究核心 (MCCMRC) 集成了质谱分析和核磁共振波谱分析,使用最先进的稳定同位素技术测量代谢物浓度及其体内动态。此外,我们提出了一项外展和教育计划,该计划将支持可行性研究,并为希望利用这些技术的研究人员提供教育和培训机会。 MCCMRC 将扩大目前提供的服务,以满足地区和国家层面调查人员日益增长的需求。我们的服务包括大规模、有针对性的代谢组学分析以及多种代谢物中稳定同位素的测量,以综合的方式使我们能够跟踪代谢物浓度的变化以及潜在的出现和消失率。这将使绘制生理学和病理状态动态代谢网络的变化成为可能。倩碧项目的特色包括在糖尿病、衰老、心血管和脂质研究以及磷酸代谢组学和药物代谢组学方法中使用稳定同位素。该计划与蛋白质组学、基因组学和药物基因组学中心相结合,并得到共同的生物信息学/生物统计学核心的支持。此外,我们与 Mayo Clinic 的主要转化研究项目紧密结合,包括个体化医学中心、再生医学中心、癌症中心、阿尔茨海默病中心、微生物组和衰老中心以及 CTSA。这使得研究结果能够快速转化为临床实践,从而改善人类健康和患者护理。该应用程序提供了与其他国家中心发展网络的机会,提供代谢组学技术的转化方法。我们将为机构、区域和国家研究人员提供分析服务以及研究设计、数学建模、样本收集和数据分析方面的专业知识。 MCCMRC 将扩大我们为访问科学家提供研讨会、短期培训和教学课程的能力,以便教育他们了解代谢组学工具的研究潜力,以及将这些技术应用到他们的研究方案中。此外,我们将利用机构培训和职业发展,在参与机构中制定以代谢训练为中心的课程和实践培训计划。我们还将提供试点和可行性资金,以寻求基于代谢组学的创新研究方法。 MCCMRC 拥有一个行政核心,负责协调和整合教育、培训和可行性计划以及技术核心的所有活动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
K Sreekumaran Nair其他文献
K Sreekumaran Nair的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('K Sreekumaran Nair', 18)}}的其他基金
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People
运动对胰岛素抵抗人群有益的分子机制
- 批准号:
10023253 - 财政年份:2019
- 资助金额:
$ 191.82万 - 项目类别:
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People
运动对胰岛素抵抗人群有益的分子机制
- 批准号:
10180841 - 财政年份:2019
- 资助金额:
$ 191.82万 - 项目类别:
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People
运动对胰岛素抵抗人群有益的分子机制
- 批准号:
10634685 - 财政年份:2019
- 资助金额:
$ 191.82万 - 项目类别:
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People
运动对胰岛素抵抗人群有益的分子机制
- 批准号:
10417138 - 财政年份:2019
- 资助金额:
$ 191.82万 - 项目类别:
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People
运动对胰岛素抵抗人群有益的分子机制
- 批准号:
10450495 - 财政年份:2019
- 资助金额:
$ 191.82万 - 项目类别:
Metformin Effect on Brain Function in Insulin Resistant Elderly People
二甲双胍对胰岛素抵抗老年人脑功能的影响
- 批准号:
10286096 - 财政年份:2018
- 资助金额:
$ 191.82万 - 项目类别:
In Vivo Regulation of Protein Turnover by Hormones
激素对蛋白质周转的体内调节
- 批准号:
8512150 - 财政年份:2012
- 资助金额:
$ 191.82万 - 项目类别:














{{item.name}}会员




